Overexpression of PPARγ can down-regulate Skp2 expression in MDA-MB-231 breast tumor cells

Molecular and Cellular Biochemistry

Volumn 345, Issue 1-2, 2010, Pages 171-180

  Meng, Jie ^a   Ding, Yun ^b   Shen, Aiguo ^a   Yan, Meijuan ^a   He, Fei ^a   Ji, Huoyan ^a   Zou, Lin ^a   Liu, Yonghua ^a   Wang, You ^b   Lu, Xiaowei ^b   Wang, Huimin ^a  

^a NANTONG UNIVERSITY   (China)

^b Department of Breast Surgery   (China)

Author keywords

Human breast cancer; Overexpression; Peroxisome proliferator activated receptors (PPARs ); S phase kinase protein (Skp2)

Indexed keywords

MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; S PHASE KINASE ASSOCIATED PROTEIN 2; TROGLITAZONE;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER GROWTH; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PROTEIN EXPRESSION; TUMOR CELL; WESTERN BLOTTING;

APOPTOSIS; BIOPSY; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LIGANDS; PPAR GAMMA; S-PHASE KINASE-ASSOCIATED PROTEINS;

EID: 78449283381     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-010-0570-y     Document Type: Article

References (26)

1. GN Hortobagyi 1998 Treatment of breast cancer N Engl J Med 339 974 984 1:CAS:528:DyaK1cXmslCitrY%3D 10.1056/NEJM199810013391407 9753714
2. J Baselga L Norton 2002 Focus on breast cancer Cancer Cell 1 319 322 1:CAS:528:DC%2BD38XktlSrtLg%3D 10.1016/S1535-6108(02)00066-1 12086846
3. DJ Mangelsdorf C Thummel M Beato, et al. 1995 The nuclear receptor superfamily: the second decade Cell 83 835 839 1:CAS:528:DyaK2MXhtVSnu7nJ 10.1016/0092-8674(95)90199-X 8521507
4. SA Kliewer BM Forman B Blumberg, et al. 1994 Differential expression and activation of a family of murine peroxisome proliferator-activated receptors Proc Natl Acad Sci USA 91 7355 7359 1:CAS:528:DyaK2cXmsFajtb0%3D 10.1073/pnas.91.15.7355 8041794
5. K Schoonjans B Staels J Auwerx 1996 The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation Biochim Biophys Acta 1302 93 109 1:STN:280:DyaK28zhtlygsA%3D%3D 8695669
6. TM Willson PJ Brown DD Sternbach, et al. 2000 The PPARs: from orphan receptors to drug discovery J Med Chem 43 527 550 1:CAS:528:DC%2BD3cXht1Churk%3D 10.1021/jm990554g 10691680
7. P Tontonoz RA Graves AI Budavari, et al. 1994 Adipocyte-specific transcription factor ARF6 is a heterodimeric complex of two nuclear hormone receptors, PPAR gamma and RXR alpha Nucleic Acids Res 22 5628 5634 1:CAS:528:DyaK2MXjtlGisLc%3D 10.1093/nar/22.25.5628 7838715
8. M Lehrke MA Lazar 2005 The many faces of PPARgamma Cell 123 993 999 1:CAS:528:DC%2BD28XptVOj 10.1016/j.cell.2005.11.026 16360030
9. HN Yu YR Lee EM Noh, et al. 2008 Induction of G1 phase arrest and apoptosis in MDA-MB-231 breast cancer cells by troglitazone, a synthetic peroxisome proliferator-activated receptor gamma (PPARgamma) ligand Cell Biol Int 32 906 912 1:CAS:528:DC%2BD1cXptVWlu7c%3D 10.1016/j.cellbi.2008.04.011 18474441
10. KI Nakayama K Nakayama 2006 Ubiquitin ligases: cell-cycle control and cancer Nat Rev Cancer 6 369 381 1:CAS:528:DC%2BD28XjslGitb4%3D 10.1038/nrc1881 16633365
11. M Gstaiger R Jordan M Lim 2001 Skp2 is oncogenic and overexpressed in human cancers Proc Natl Acad Sci USA 98 5043 5048 1:CAS:528:DC%2BD3MXjt1Ogu7c%3D 10.1073/pnas.081474898 11309491
12. S Signoretti L Di Marcotullio A Richardson, et al. 2002 Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer J Clin Investig 110 633 641 1:CAS:528:DC%2BD38Xmslyitrs%3D 12208864
13. H Koga M Harada M Ohtsubo, et al. 2003 Troglitazone induces p27Kip1-associated cell-cycle arrest through down-regulating Skp2 in human hepatoma cells Hepatology 37 1086 1096 1:CAS:528:DC%2BD3sXktVWnsLw%3D 10.1053/jhep.2003.50186 12717389
14. DC Allred JM Harvey M Berardo, et al. 1998 Prognostic and predictive factors in breast cancer by immunohistochemical analysis Mod Pathol 11 155 168 1:STN:280:DyaK1c7mtlaitg%3D%3D 9504686
15. S Davidovich O Ben-Izhak M Shapira, et al. 2008 Over-expression of Skp2 is associated with resistance to preoperative doxorubicin-based chemotherapy in primary breast cancer Breast Cancer Res 10 R63 10.1186/bcr2122 18644126
16. A Ravaioli F Monti MM Regan, et al. 2008 p27 and Skp2 immunoreactivity and its clinical significance with endocrine and chemo-endocrine treatments in node-negative early breast cancer Ann Oncol 19 660 668 1:STN:280: DC%2BD1c3gsFWgtg%3D%3D 10.1093/annonc/mdm547 18272916
17. Y Jiang L Zou C Zhang, et al. 2009 PPARgamma and Wnt/beta-Catenin pathway in human breast cancer: expression pattern, molecular interaction and clinical/prognostic correlations J Cancer Res Clin Oncol 135 1551 1559 1:CAS:528:DC%2BD1MXhtFCjtb%2FF 10.1007/s00432-009-0602-8 19495794
18. GM Cohen 1997 Caspases: the executioners of apoptosis Biochem J 326 Pt 1 1 16 1:CAS:528:DyaK2sXlvFChsL4%3D 9337844
19. C Qin D Morrow J Stewart, et al. 2004 A new class of peroxisome proliferator-activated receptor gamma (PPARgamma) agonists that inhibit growth of breast cancer cells: 1,1-Bis(3′-indolyl)-1-(p-substituted phenyl)methanes Mol Cancer Ther 3 247 260 1:CAS:528:DC%2BD2cXitFCnsrc%3D 15026545
20. H Koutnikova J Auwerx 2002 PPARgamma, an X-ceptor for Xs Ann N Y Acad Sci 967 28 33 1:CAS:528:DC%2BD38XlvVKqtbc%3D 10.1111/j.1749-6632.2002.tb04260.x 12079832
21. JM Lehmann LB Moore TA Smith-Oliver, et al. 1995 An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator- activated receptor gamma (PPAR gamma) J Biol Chem 270 12953 12956 1:CAS:528:DyaK2MXmtV2itr0%3D 10.1074/jbc.270.50.30221 7768881
22. E Mueller P Sarraf P Tontonoz, et al. 1998 Terminal differentiation of human breast cancer through PPAR gamma Mol Cell 1 465 470 1:CAS:528: DyaK1cXhtlyhurk%3D 10.1016/S1097-2765(00)80047-7 9660931
23. RF Morrison SR Farmer 1999 Role of PPARgamma in regulating a cascade expression of cyclin-dependent kinase inhibitors, p18(INK4c) and p21(Waf1/Cip1), during adipogenesis J Biol Chem 274 17088 17097 1:CAS:528:DyaK1MXjvVGkur8%3D 10.1074/jbc.274.24.17088 10358062
24. S Altiok M Xu BM Spiegelman 1997 PPARgamma induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A Genes Dev 11 1987 1998 1:CAS:528:DyaK2sXlsVSmsbc%3D 10.1101/gad.11.15.1987 9271121
25. TM Garcia-Bates SH Bernstein RP Phipps 2008 Peroxisome proliferator-activated receptor gamma overexpression suppresses growth and induces apoptosis in human multiple myeloma cells Clin Cancer Res 14 6414 6425 1:CAS:528:DC%2BD1cXht1KgtbvP 10.1158/1078-0432.CCR-08-0457 18927280
26. TA Masuda H Inoue H Sonoda, et al. 2002 Clinical and biological significance of S-phase kinase-associated protein 2 (Skp2) gene expression in gastric carcinoma: modulation of malignant phenotype by Skp2 overexpression, possibly via p27 proteolysis Cancer Res 62 3819 3825 1:CAS:528: DC%2BD38XltF2jurY%3D 12097295